Literature DB >> 15042426

Nd:YAG laser induces long-term remission in transfusion-dependent patients with watermelon stomach.

N G Mathou1, L B Lovat, S M Thorpe, S G Bown.   

Abstract

Watermelon stomach (gastric antral vascular ectasia) is a rare cause of gastric bleeding which can render patients transfusion-dependent. Laser therapy can be used to stop bleeding but the long-term success of this approach is not well described. We present a retrospective analysis of 24 consecutive transfusion-dependent patients who were treated in a national referral centre with Nd:YAG laser over an 18 year period. Laser therapy stopped all bleeding in 20 patients (83%) after a median of two sessions. Median follow up was 55 months (range 9-127). Patients remained transfusion free for a median of 16 months and a second course of treatment succeeded in all those who re-bled. One gastric perforation occurred early in the series and two patients developed pyloric stenosis which was successfully treated with balloon pyloric dilatation. Oestrogens were not used in these patients. Our experience shows that long-term remission from blood transfusion is seen in most patients treated with Nd:YAG laser. If bleeding recurs, further laser treatment is usually successful.

Entities:  

Mesh:

Year:  2004        PMID: 15042426     DOI: 10.1007/s10103-003-0284-4

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  30 in total

1.  Bipolar electrocoagulation for watermelon stomach.

Authors:  K F Binmoeller; R M Katon
Journal:  Gastrointest Endosc       Date:  1990 Jul-Aug       Impact factor: 9.427

2.  Gastric antral vascular ectasia (watermelon stomach)--therapeutic options.

Authors:  R H Park; B J Danesh; R Upadhyay; A G Howatson; F D Lee; R I Russell
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

3.  Gastric antral vascular ectasia: maintenance treatment with oestrogen-progesterone.

Authors:  S F Moss; P Ghosh; D M Thomas; J E Jackson; J Calam
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

Review 4.  Watermelon stomach. An unusual cause of recurrent upper GI tract bleeding in the uraemic patient: efficient treatment with oestrogen-progesterone therapy.

Authors:  C Hermans; E Goffin; Y Horsmans; E Laterre; C Van Ypersele de Strihou
Journal:  Nephrol Dial Transplant       Date:  1996-05       Impact factor: 5.992

5.  Argon plasma coagulation for treatment of watermelon stomach.

Authors:  I Yusoff; F Brennan; D Ormonde; B Laurence
Journal:  Endoscopy       Date:  2002-05       Impact factor: 10.093

6.  Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia. Lack of response to portosystemic shunt or gastrectomy.

Authors:  P Calès; J J Voigt; J L Payen; E Bloom; P Berg; J P Vinel; B Pradère; P Broussy; J P Pascal
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

7.  Laser ablation of upper gastrointestinal vascular ectasias: long term results.

Authors:  I R Sargeant; L A Loizou; D Rampton; M Tulloch; S G Bown
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

Review 8.  The stomach in cirrhosis. The legend of Proteus retold.

Authors:  T Lingenfelser; J E Krige
Journal:  J Clin Gastroenterol       Date:  1993-09       Impact factor: 3.062

9.  The watermelon stomach: long-term outcome in patients treated with Nd:YAG laser therapy.

Authors:  S M Liberski; T J McGarrity; R J Hartle; V Varano; D Reynolds
Journal:  Gastrointest Endosc       Date:  1994 Sep-Oct       Impact factor: 9.427

10.  Dramatic improvement of watermelon stomach with alpha-interferon.

Authors:  P Disdier; N Schleinitz; M Perreard; D Monges; L Swiader; A Gérolami; J R Harlé; P J Weiller
Journal:  Am J Gastroenterol       Date:  1995-06       Impact factor: 10.864

View more
  9 in total

1.  Laser therapy and surgical treatment in transfusion-dependent patients with upper-gastrointestinal vascular ectasia.

Authors:  Lino Polese; Imerio Angriman; Duilio Pagano; Maria L Tenderini; Francesca Polese; Mauro Frego; Davide F D'Amico; Lorenzo Norberto
Journal:  Lasers Med Sci       Date:  2006-07-29       Impact factor: 3.161

Review 2.  Management of gastropathy and gastric vascular ectasia in portal hypertension.

Authors:  Cristina Ripoll; Guadalupe Garcia-Tsao
Journal:  Clin Liver Dis       Date:  2010-05       Impact factor: 6.126

3.  Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia.

Authors:  Cormac Magee; Gideon Lipman; Durayd Alzoubaidi; Martin Everson; Rami Sweis; Matthew Banks; David Graham; Charles Gordon; Laurence Lovat; Charles Murray; Rehan Haidry
Journal:  United European Gastroenterol J       Date:  2018-11-15       Impact factor: 4.623

4.  Treatment of watermelon stomach.

Authors:  Gareth S Dulai; Dennis M Jensen
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

5.  Diagnosis and management of gastric antral vascular ectasia.

Authors:  Lorenzo Fuccio; Alessandro Mussetto; Liboria Laterza; Leonardo Henry Eusebi; Franco Bazzoli
Journal:  World J Gastrointest Endosc       Date:  2013-01-16

6.  Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension.

Authors:  Cristina Ripoll; Guadalupe Garcia-Tsao
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

Review 7.  Portal hypertensive gastropathy and gastric antral vascular ectasia.

Authors:  Hitendra Garg; Subhash Gupta; A C Anand; S L Broor
Journal:  Indian J Gastroenterol       Date:  2015-11-13

Review 8.  Gastric antral vascular ectasia: the evolution of therapeutic modalities.

Authors:  Harini Naidu; Qin Huang; Hiroshi Mashimo
Journal:  Endosc Int Open       Date:  2014-05-15

Review 9.  Insights into the management of gastric antral vascular ectasia (watermelon stomach).

Authors:  Wen-Hung Hsu; Yao-Kuang Wang; Meng-Shu Hsieh; Fu-Chen Kuo; Meng-Chieh Wu; Hsiang-Yao Shih; I-Chen Wu; Fang-Jung Yu; Huang-Ming Hu; Yu-Chung Su; Deng-Chyang Wu
Journal:  Therap Adv Gastroenterol       Date:  2018-01-14       Impact factor: 4.409

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.